Caplin Point Laboratories Ltd. | Mutual Funds
Mutual Funds that own Caplin Point Laboratories Ltd.
Matthews India Fund
3,697,744
4.88%
520,343
1.05%
06/29/2018
Matthews Emerging Asia Fund
489,805
0.65%
0
0.63%
06/29/2018
226,796
0.3%
0
1.28%
06/30/2018
DFA Emerging Markets Core Equity Portfolio
151,305
0.2%
5,974
0%
04/30/2018
EP Asia Small Companies Fund
121,508
0.16%
121,508
1.07%
04/30/2018
DFA Emerging Markets Small Cap Series
120,778
0.16%
34,871
0.01%
01/31/2018
iShares MSCI India Small Cap ETF
48,768
0.07%
0
0.11%
09/05/2018
WIOF India Performance Fund
38,983
0.05%
0
1.77%
02/28/2018
SPDR S&P Emerging Markets ETF
21,554
0.03%
0
0.01%
09/06/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
13,505
0.02%
0
0.01%
12/31/2017
| Address |
Narbavi
Chennai Tamil Nadu 600017
India
|
|
Employees
|
- |
| Website |
http://www.caplinpoint.net |
| Updated |
09/14/2018 |
| Caplin Point Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It offers antibiotics, non-steroidal anti-inflammatory drugs (NSAIDS), ophthalmics, pain management, and anti-ulcer products. The company was founded on April 16, 1990 and is headquartered in Chennai, India. |
